3T Biosciences
- Biotech or pharma, therapeutic R&D
3T Biosciences is an immunotherapy company committed to unlocking the ability of the immune system to enable elite responses in all patients. 3T's lead pHLA/CD3 bispecific program, 3T-403, is in IND enabling development and scheduled to enter the clinic for solid tumors in early 2026.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}